Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CYCLOPHOSPHAMIDE for Bone marrow conditioning regimen: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 4,485 adverse event reports in the FDA FAERS database where CYCLOPHOSPHAMIDE was used for Bone marrow conditioning regimen.

Most Reported Side Effects for CYCLOPHOSPHAMIDE

Side Effect Reports % Deaths Hosp.
Off label use 12,578 9.8% 2,788 3,928
Febrile neutropenia 11,318 8.8% 1,348 7,223
Drug ineffective 8,142 6.3% 2,157 2,184
Neutropenia 7,352 5.7% 1,287 2,890
Disease progression 7,100 5.5% 1,730 1,008
Pyrexia 6,126 4.8% 832 4,228
Product use in unapproved indication 5,750 4.5% 1,245 1,392
Thrombocytopenia 4,669 3.6% 902 1,799
Pneumonia 4,595 3.6% 1,633 2,604
Nausea 4,561 3.6% 363 2,190
Anaemia 4,486 3.5% 664 2,040
Death 4,270 3.3% 4,260 453
Sepsis 4,041 3.1% 2,077 1,841
Myelosuppression 3,603 2.8% 209 1,796
Diarrhoea 3,602 2.8% 566 1,861

Other Indications for CYCLOPHOSPHAMIDE

Diffuse large b-cell lymphoma (16,598) Plasma cell myeloma (9,148) Breast cancer (8,826) Product used for unknown indication (8,261) Acute lymphocytic leukaemia (5,495) B-cell lymphoma (4,766) Non-hodgkin's lymphoma (3,805) Chemotherapy (3,372) Chronic lymphocytic leukaemia (3,085) Prophylaxis against graft versus host disease (2,727)

Other Drugs Used for Bone marrow conditioning regimen

FLUDARABINE (6,080) BUSULFAN (4,669) MELPHALAN (2,368) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884) THIOTEPA (1,551) ALEMTUZUMAB (1,122) ETOPOSIDE (936) CYTARABINE (833) THYMOCYTE IMMUNE GLOBULIN NOS (742) TREOSULFAN (695)

Related Pages

CYCLOPHOSPHAMIDE Full Profile All Bone marrow conditioning regimen Drugs CYCLOPHOSPHAMIDE Demographics CYCLOPHOSPHAMIDE Timeline